Acuamark Diagnostics
New York
About Acuamark Diagnostics
Acuamark Diagnostics develops technology that allows for a highly accurate screening of blood to detect cancer markers at the early cancer stages before cancer becomes untreatable. Backed by a highly experienced team of scientific and business professionals, it is its mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, early detection. It was founded in 2012 and is headquartered in New York, New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2022)
- Website: acuamarkdx.com
- Phone: (212)972-0077
Industries & Categories
Biotechnology, Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/acuamark-diagnostics-19751 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.